Janssen Search
Search results
Clinical Trials
Janssen Clinical Innovation Janssen is striving to develop and implement new approaches to improve the clinical trial process for all stakeholders: patients, trial sites/investigators and the healthcare industry at large. Janssen Clinical Innovation (JCI) ...
Janssen Immunology Storytellers
Janssen Storytellers Series: Meet Brian We’re proud to share the story of Brian, one of our Janssen Immunology scientists who is dedicated to innovation for people living with and susceptible to immune diseases. Stay tuned for more videos in the ...
About Our Global Public Health Initiative
Janssen’s Commitment to Global Public Health At Janssen, the Pharmaceutical Companies of Johnson & Johnson, we have a single overarching mission: to address and solve the most important unmet medical needs of our time. Janssen aims to build on our ...
Ann Beliën, Ph.D.
Ann Beliën contributes to development of the Janssen Prevention Center’s discovery portfolio in two main ways. In her Management Team role as Head of Strategy, she is responsible for providing the Global Head of the Janssen Prevention Center with a clear ...
Our Diabetes & Cardiovascular Affiliates
Johnson & Johnson in Diabetes & Cardiovascular The various Johnson & Johnson Family of Diabetes Companies and Cardiovascular Care are working together to bring innovative solutions to meet the needs of people affected by diabetes and their ...
R&D Focus Areas
Our Areas of Focus We leverage our world-class discovery and development expertise, as well as our operational excellence, to bring innovative, effective treatments in six therapeutic areas and advanced biotherapeutic and research platforms: ...
A Collaborative Model
Article Type: Human Microbiome Institute A Collaborative Model We believe that fostering cooperation and partnerships within the scientific and medical communities is essential to effectively translate promising microbiome science into solutions that ...
BIO-Europe Spring 2018
BIO-Europe Spring 2018 will take place March 12- 14, 2018, in Amsterdam. The conference brings together hundreds of the world’s most innovative leaders across biotech, finance and pharma for high-level networking, pre-scheduled partnering meetings, ...
JCI in the News
An Eye for Innovation "Mastering the Virtual Clinical Trial" Remaking Clinical Trials with the Patient in Mind DPHARM 2019: Emerging Technologies Set to Disrupt Clinical Trials How Janssen Uses Technology to Create Patient-Centric Trials Janssen ...
Fighting Multi-Drug Resistant Tuberculosis
Fighting Multi-Drug Resistant Tuberculosis (MDR-TB) Creating Long-Term, Sustainable Solutions More than 480,000 new cases of multi-drug resistant tuberculosis (MDR-TB) were reported worldwide in 2013, and only 20 percent of MDR-TB patients were enrolled ...